Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for quality of life in adults with plaque psoriasis
2018-002850-58Phase 4Unknown
- Sponsor
- Amgen
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in plaque psoriasis comparing Apremilast with Placebo (2 arms). Primary endpoint: Dermatology Life Quality Index response at Week 16. Status: unknown.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2018-002850-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002850-58.